Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 104

1.

Prognostic factors in nasopharyngeal carcinoma with synchronous liver metastasis: a retrospective study for the management of treatment.

Tian YM, Zeng L, Wang FH, Liu S, Guan Y, Lu TX, Han F.

Radiat Oncol. 2013 Nov 19;8:272. doi: 10.1186/1748-717X-8-272.

PMID:
24252126
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Baseline serum lactate dehydrogenase levels for patients treated with intensity-modulated radiotherapy for nasopharyngeal carcinoma: a predictor of poor prognosis and subsequent liver metastasis.

Zhou GQ, Tang LL, Mao YP, Chen L, Li WF, Sun Y, Liu LZ, Li L, Lin AH, Ma J.

Int J Radiat Oncol Biol Phys. 2012 Mar 1;82(3):e359-65. doi: 10.1016/j.ijrobp.2011.06.1967. Epub 2011 Oct 12. Erratum in: Int J Radiat Oncol Biol Phys. 2013 Jun 1;86(2):213.

PMID:
22000748
[PubMed - indexed for MEDLINE]
3.

[Prognosis analysis of nasopharyngeal carcinoma patients with distant metastasis].

Wang CT, Cao KJ, Li Y, Xie GF, Huang PY.

Ai Zheng. 2007 Feb;26(2):212-5. Chinese.

PMID:
17298756
[PubMed - indexed for MEDLINE]
4.
5.

Prognostic features and treatment outcome in locoregionally advanced nasopharyngeal carcinoma following concurrent chemotherapy and radiotherapy.

Cheng SH, Jian JJ, Tsai SY, Chan KY, Yen LK, Chu NM, Tan TD, Tsou MH, Huang AT.

Int J Radiat Oncol Biol Phys. 1998 Jul 1;41(4):755-62.

PMID:
9652835
[PubMed - indexed for MEDLINE]
6.

Retrospective analysis of 234 nasopharyngeal carcinoma patients with distant metastasis at initial diagnosis: therapeutic approaches and prognostic factors.

Zeng L, Tian YM, Huang Y, Sun XM, Wang FH, Deng XW, Han F, Lu TX.

PLoS One. 2014 Sep 23;9(9):e108070. doi: 10.1371/journal.pone.0108070. eCollection 2014.

PMID:
25247415
[PubMed - in process]
Free PMC Article
7.

Serum lactate dehydrogenase level is a prognostic factor in patients with locoregionally advanced nasopharyngeal carcinoma treated with chemoradiotherapy.

Turen S, Ozyar E, Altundag K, Gullu I, Atahan IL.

Cancer Invest. 2007 Aug;25(5):315-21.

PMID:
17661206
[PubMed - indexed for MEDLINE]
8.

Non-metastatic stage IV nasopharyngeal carcinoma patients: analysis of the pattern of relapse and survival.

Ozyar E, Gurkaynak M, Yildiz F, Atahan IL.

Radiother Oncol. 2004 Jul;72(1):71-7.

PMID:
15236877
[PubMed - indexed for MEDLINE]
9.

Prognostic value of tumor volume for patients with nasopharyngeal carcinoma treated with concurrent chemotherapy and intensity-modulated radiotherapy.

Wu Z, Su Y, Zeng RF, Gu MF, Huang SM.

J Cancer Res Clin Oncol. 2014 Jan;140(1):69-76. doi: 10.1007/s00432-013-1542-x. Epub 2013 Oct 31.

PMID:
24173695
[PubMed - indexed for MEDLINE]
10.

Risk subset of the survival for nasopharyngeal carcinoma patients with bone metastases: who will benefit from combined treatment?

Cao X, Han Y, He L, Xiang J, Wen Z.

Oral Oncol. 2011 Aug;47(8):747-52. doi: 10.1016/j.oraloncology.2011.05.010. Epub 2011 Jun 12.

PMID:
21665523
[PubMed - indexed for MEDLINE]
11.

Locoregional radiotherapy in patients with distant metastases of nasopharyngeal carcinoma at diagnosis.

Chen MY, Jiang R, Guo L, Zou X, Liu Q, Sun R, Qiu F, Xia ZJ, Huang HQ, Zhang L, Hong MH, Mai HQ, Qian CN.

Chin J Cancer. 2013 Nov;32(11):604-13. doi: 10.5732/cjc.013.10148.

PMID:
24206918
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

[Prognosis and treatment strategies of primary B-cell and NK/T-cell nasopharyngeal non-Hodgkin's lymphoma at early stage].

Zou GR, Zhang YJ, Xie FY, Zheng W, Li HX, Xia YF, Lin TY, Lu TX.

Ai Zheng. 2006 Dec;25(12):1543-9. Chinese.

PMID:
17166383
[PubMed - indexed for MEDLINE]
13.

Comparing treatment outcomes of different chemotherapy sequences during intensity modulated radiotherapy for advanced N-stage nasopharyngeal carcinoma patients.

Sun X, Zeng L, Chen C, Huang Y, Han F, Xiao W, Liu S, Lu T.

Radiat Oncol. 2013 Nov 13;8:265. doi: 10.1186/1748-717X-8-265.

PMID:
24219818
[PubMed - indexed for MEDLINE]
Free PMC Article
14.

The prognostic influence of prevertebral space involvement in nasopharyngeal carcinoma.

Lee CC, Chu ST, Chou P, Lee CC, Chen LF.

Clin Otolaryngol. 2008 Oct;33(5):442-9. doi: 10.1111/j.1749-4486.2008.01770.x.

PMID:
18983377
[PubMed - indexed for MEDLINE]
15.

Prognostic factors of 305 nasopharyngeal carcinoma patients treated with intensity-modulated radiotherapy.

Han L, Lin SJ, Pan JJ, Chen CB, Zhang Y, Zhang XC, Liao XY, Chen QS.

Chin J Cancer. 2010 Feb;29(2):145-50.

PMID:
20109341
[PubMed - indexed for MEDLINE]
Free Article
16.

Prognosticators and risk grouping in patients with lung metastasis from nasopharyngeal carcinoma: a more accurate and appropriate assessment of prognosis.

Cao X, Luo RZ, He LR, Li Y, Lin WQ, Chen YF, Wen ZS.

Radiat Oncol. 2011 Aug 26;6:104. doi: 10.1186/1748-717X-6-104.

PMID:
21871101
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

Survival outcome of patients with nasopharyngeal carcinoma with first local failure: a study by the Hong Kong Nasopharyngeal Carcinoma Study Group.

Yu KH, Leung SF, Tung SY, Zee B, Chua DT, Sze WM, Law SC, Kam MK, Leung TW, Sham JS, Lee AW, Au JS, Hui EP, Sze WK, Cheng AC, Yau TK, Ngan RK, Wong FC, Au GK, Chan AT; Hong Kong Nasopharyngeal Carcinoma Study Group.

Head Neck. 2005 May;27(5):397-405.

PMID:
15726589
[PubMed - indexed for MEDLINE]
18.

Prognostic factors and outcome for nasopharyngeal carcinoma.

Farias TP, Dias FL, Lima RA, Kligerman J, de Sá GM, Barbosa MM, Gonçalves FB Jr.

Arch Otolaryngol Head Neck Surg. 2003 Jul;129(7):794-9.

PMID:
12874084
[PubMed - indexed for MEDLINE]
19.

Induction chemotherapy with mitomycin, epirubicin, cisplatin, fluorouracil, and leucovorin followed by radiotherapy in the treatment of locoregionally advanced nasopharyngeal carcinoma.

Hong RL, Ting LL, Ko JY, Hsu MM, Sheen TS, Lou PJ, Wang CC, Chung NN, Lui LT.

J Clin Oncol. 2001 Dec 1;19(23):4305-13.

PMID:
11731513
[PubMed - indexed for MEDLINE]
20.

Radiofrequency ablation combined with systemic chemotherapy in nasopharyngeal carcinoma liver metastases improves response to treatment and survival outcomes.

Jin Y, Cai YC, Cao Y, Cai XY, Tan YT, Shi YX, Jiang WQ.

J Surg Oncol. 2012 Sep 1;106(3):322-6. doi: 10.1002/jso.23034. Epub 2012 Jan 23.

PMID:
22271524
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk